country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-P11422

Copy Link Print Information

CKS9

CKS9 is an M cell-targeting polypeptide with the amino acid sequence CKSTHPLSC, forming a 9-mer peptide via cyclization through a disulfide bond between the two cysteine residues. CKS9 is obtained through phage display technology screening and has high affinity for M cells. CKS9 can promote chitosan nanoparticles to cross M cells and enter the follicle-associated epithelium (FAE) of intestinal Peyer's patches (PP). CKS9 can be used in studies related to swine dysentery and oral delivery.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Formel: C₃₉H₆₄N₁₂O₁₃S₂
Molecular Weight:973.13

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

CKS9 Chemical Structure

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- In Vitro
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

In Vitro

CKS9 can be successfully grafted onto stearic acid esterified starch to form SES@CKS9-1 and SES@CKS9-2^[1].
CKS9-modified SES exhibits stronger binding affinity to integrin α5β1 than unmodified SES. CKS9 mediates key hydrogen-bond interactions at the interface of the βI/β-propeller domain of integrin, suggesting that integrin α5β1 is a potential M cell receptor for CKS9^[1].
CKS9 is conjugated with WSC via EDC/NHS, with a molar ratio of 6.37 mol%^[2].
As the C-terminal component of a computationally designed multi-epitope oral vaccine against *Helicobacter pylori*, CKS9 targets intestinal epithelial microfold cells to enhance the intestinal barrier uptake of the vaccine^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

Molecular Weight 973.13
Formel C₃₉H₆₄N₁₂O₁₃S₂
Sequence

Cys-Lys-Ser-Thr-His-Pro-Leu-Ser-Cys (Disulfide bridge:Cys1-Cys9)
Sequence Shortening

CKSTHPLSC (Disulfide bridge:Cys1-Cys9)
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (260 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Wang T, et al. Development of M cell-targeting starch-based nanomicelles for oral delivery of immunoactive peptides[J]. Industrial Crops and Products, 2022, 184: 115074.

[2]. Jiang T, et al. Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan. Biomaterials. 2014 Feb;35(7):2365-73. [Content Brief]

[3]. Urrutia-Baca VH, et al. Immunoinformatics Approach to Design a Novel Epitope-Based Oral Vaccine Against Helicobacter pylori. J Comput Biol. 2019 Oct;26(10):1177-1190.

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen